Immunotherapy and Cancer: Harnessing the Power of Diagnostic Assays

In this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.

Multiplexed Mass Spectrometry Solutions for Cancer Proteomics

In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.

Conquering CML: The Breakthrough Paradigm Change of Treatment-free Remission

Download this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.
video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Researchers Operating Chemistry Analyzer Machine

Better Understanding of Post-Translation Modifications Driving Innovation

Takeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.

Unlocking Value in Clinical Diagnostics

Panelists will discuss how to navigate the clinical diagnostic marketplace and what to consider when developing new assays.
video

The Promise and Challenge of Immuno-Oncology

This webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.
video

Liquid Biopsy Thrusts Non-Invasive Molecular Diagnostics into the Clinical Arena

Explore how liquid biopsies shape the diagnostic landscape and impact physician decision making and patient care.
Scroll Up